Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,931 | 478 | 98.7% |
| Education | $106.26 | 7 | 1.1% |
| Consulting Fee | $19.76 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,238 | 57 | $0 (2020) |
| Amgen Inc. | $896.47 | 30 | $0 (2020) |
| PFIZER INC. | $865.19 | 52 | $0 (2020) |
| Novo Nordisk Inc | $863.36 | 42 | $0 (2024) |
| GlaxoSmithKline, LLC. | $791.17 | 39 | $0 (2024) |
| Merck Sharp & Dohme LLC | $691.36 | 40 | $0 (2024) |
| Astellas Pharma US Inc | $522.02 | 25 | $0 (2020) |
| Lilly USA, LLC | $472.78 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $456.21 | 22 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $370.58 | 14 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.39 | 11 | Lilly USA, LLC ($119.25) |
| 2023 | $18.75 | 1 | GlaxoSmithKline, LLC. ($18.75) |
| 2021 | $12.96 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12.96) |
| 2020 | $565.26 | 28 | PFIZER INC. ($75.23) |
| 2019 | $3,447 | 166 | AstraZeneca Pharmaceuticals LP ($769.10) |
| 2018 | $2,612 | 123 | Amgen Inc. ($365.63) |
| 2017 | $3,145 | 156 | Novo Nordisk Inc ($354.22) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.00 | General |
| 04/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Obesity | ||||||
| 03/28/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY, BEXSERO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: VACCINES | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Obesity | ||||||
| 01/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Obesity | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: DIABETES | ||||||
| 03/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: VACCINES | ||||||
| 03/12/2020 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: WOMENS HEALTH | ||||||
| 03/05/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | Hologic, LLC | Aptima HPV (Device), Aptima Combo 2, Aptima TV | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diagnostics | ||||||
| 03/01/2020 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $20.45 | General |
| Category: Cardiovascular | ||||||
| 02/28/2020 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug), VYLEESI | Education | In-kind items and services | $20.89 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/26/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: VACCINES | ||||||
| 02/25/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Bone Health | ||||||
| 02/24/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Respiratory | ||||||
| 02/21/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 649 | 887 | $229,345 | $67,808 |
| 2022 | 16 | 678 | 1,036 | $215,184 | $63,461 |
| 2021 | 13 | 557 | 848 | $107,634 | $54,147 |
| 2020 | 16 | 673 | 1,121 | $147,215 | $63,572 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 422 | $145,590 | $39,986 | 27.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 64 | 64 | $22,656 | $8,983 | 39.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 53 | $25,705 | $7,469 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 94 | $23,030 | $5,812 | 25.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 30 | 30 | $3,990 | $2,274 | 57.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $960.00 | $940.80 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 74 | $962.00 | $621.60 | 64.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $510.00 | $499.80 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 43 | 44 | $1,716 | $499.68 | 29.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 17 | 22 | $3,190 | $438.20 | 13.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 15 | $836.00 | $215.46 | 25.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 20 | $200.00 | $68.20 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 366 | $126,270 | $35,826 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $20,532 | $8,486 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 117 | $28,665 | $7,326 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 45 | $21,825 | $6,014 | 27.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 19 | 20 | $1,300 | $1,279 | 98.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 61 | 70 | $2,730 | $769.16 | 28.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 44 | $2,860 | $737.47 | 25.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 20 | $600.00 | $600.13 | 100.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $510.00 | $514.68 | 100.9% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 11 | 11 | $759.00 | $490.16 | 64.6% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 23 | 30 | $4,350 | $469.67 | 10.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 92 | 125 | $1,625 | $370.08 | 22.8% |
| 85610 | Blood test, clotting time | Office | 2022 | 11 | 70 | $2,240 | $296.53 | 13.2% |
About Dr. Robert Ranney, MD
Dr. Robert Ranney, MD is a Family Medicine healthcare provider based in Brea, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902807670.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ranney, MD has received a total of $10,057 in payments from pharmaceutical and medical device companies, with $255.39 received in 2024. These payments were reported across 486 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($9,931).
As a Medicare-enrolled provider, Ranney has provided services to 2,557 Medicare beneficiaries, totaling 3,892 services with total Medicare billing of $248,988. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Brea, CA
- Active Since 08/03/2005
- Last Updated 11/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902807670
Products in Payments
- FARXIGA (Drug) $634.92
- Prolia (Biological) $599.77
- JARDIANCE (Drug) $389.21
- Livalo (Drug) $370.58
- JANUVIA (Drug) $323.29
- Myrbetriq (Drug) $266.82
- SYMBICORT (Drug) $266.14
- MYRBETRIQ (Drug) $255.20
- CHANTIX (Drug) $255.05
- Saxenda (Drug) $246.12
- BREO (Drug) $232.79
- TRADJENTA (Drug) $219.41
- Trintellix (Drug) $206.09
- TRELEGY ELLIPTA (Drug) $202.90
- Androgel (Drug) $197.05
- LYRICA (Drug) $180.39
- Ozempic (Drug) $164.46
- Vascepa (Drug) $164.01
- Aimovig (Biological) $152.94
- Tresiba (Drug) $149.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brea
Dennis Shults, Do, DO
Family Medicine — Payments: $181,159
Debra Gutierrez, Md, MD
Family Medicine — Payments: $17,759
Dr. Kedy Jao, D.o, D.O
Family Medicine — Payments: $11,416
Andrew Morrison, Md, MD
Family Medicine — Payments: $10,716
John Mitchell, M.d, M.D
Family Medicine — Payments: $10,229
A Thomas Parsa, M.d, M.D
Family Medicine — Payments: $9,243